Silver Creek Pharmaceuticals
« Back to PortfolioSilver Creek is developing novel regenerative medicines with an initial focus on treating cardiovascular disease. The seed for Silver Creek’s approach was based on insights from work at Merrimack Pharmaceuticals in the field of oncology: at the systems level, tumor cells and cardiomyocytes share very similar mechanisms of survival during stress; however, the cardiomyocytes are not as resilient.
